Judith R Fay

Summary

Publications

  1. ncbi request reprint Targeting epigenetic regulatory mechanisms in cancer chemoprevention
    Judith R Fay
    CCS Associates, 2005 Landings Dr, Mountain View, CA 94043, USA
    Expert Opin Ther Targets 9:315-28. 2005
  2. doi request reprint Energy homeostasis and cancer prevention: the AMP-activated protein kinase
    Judith R Fay
    CCS Associates, Mountain View, CA 94043, USA
    Cancer Prev Res (Phila) 2:301-9. 2009
  3. ncbi request reprint Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents
    Levy Kopelovich
    CCS Associates, Mountain View, California 94043, USA
    Mol Cancer Ther 1:357-63. 2002
  4. ncbi request reprint The epigenome as a target for cancer chemoprevention
    Levy Kopelovich
    Chemopreventive Agent Development Research Group, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:1747-57. 2003
  5. ncbi request reprint The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention
    Levy Kopelovich
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 16:1330-40. 2007
  6. ncbi request reprint Targeting the AKT protein kinase for cancer chemoprevention
    James A Crowell
    Division of Cancer Prevention, National Cancer Institute, NIH, Executive Plaza North, Room 2117, 900 Rockville Pike, Bethesda, MD 20892, USA
    Mol Cancer Ther 6:2139-48. 2007

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Targeting epigenetic regulatory mechanisms in cancer chemoprevention
    Judith R Fay
    CCS Associates, 2005 Landings Dr, Mountain View, CA 94043, USA
    Expert Opin Ther Targets 9:315-28. 2005
    ..This review discusses the potential for restoring epigenetic balance as a means to prevent cancer...
  2. doi request reprint Energy homeostasis and cancer prevention: the AMP-activated protein kinase
    Judith R Fay
    CCS Associates, Mountain View, CA 94043, USA
    Cancer Prev Res (Phila) 2:301-9. 2009
    ..Because dysregulated energy balance is a nexus for multiple chronic diseases of aging, drugs that target these pathways may find broad utility in aging populations...
  3. ncbi request reprint Peroxisome proliferator-activated receptor modulators as potential chemopreventive agents
    Levy Kopelovich
    CCS Associates, Mountain View, California 94043, USA
    Mol Cancer Ther 1:357-63. 2002
    ..This review presents a rationale for using PPAR modulators as cancer chemopreventive drugs...
  4. ncbi request reprint The epigenome as a target for cancer chemoprevention
    Levy Kopelovich
    Chemopreventive Agent Development Research Group, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Natl Cancer Inst 95:1747-57. 2003
    ....
  5. ncbi request reprint The mammalian target of rapamycin pathway as a potential target for cancer chemoprevention
    Levy Kopelovich
    Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cancer Epidemiol Biomarkers Prev 16:1330-40. 2007
    ..These findings, together with the intriguing possibility that mTOR suppression may be associated with antitumor actions of caloric restriction, suggest that mTOR signaling may be an important target for chemopreventive drugs...
  6. ncbi request reprint Targeting the AKT protein kinase for cancer chemoprevention
    James A Crowell
    Division of Cancer Prevention, National Cancer Institute, NIH, Executive Plaza North, Room 2117, 900 Rockville Pike, Bethesda, MD 20892, USA
    Mol Cancer Ther 6:2139-48. 2007
    ....